Literature DB >> 23998985

The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism.

Sivaraman Purushothuman1, Charith Nandasena, Daniel M Johnstone, Jonathan Stone, John Mitrofanis.   

Abstract

We have examined whether near-infrared light (NIr) treatment mitigates oxidative stress and increased expression of hyperphosphorylated tau in a tau transgenic mouse strain (K3) that has a progressive degeneration of dopaminergic cells in the substantia nigra pars compacta (SNc). The brains of wild-type (WT), untreated K3 and NIr-treated K3 mice, aged five months (thus after the onset of parkinsonian signs and neuropathology), were labelled immunohistochemically for the oxidative stress markers 4-hydroxynonenal (4-HNE) and 8-hydroxy-2'-deoxyguanosine (8-OHDG), hyperphosphorylated tau (using the AT8 antibody) and tyrosine hydroxylase (TH). The average intensity and area of 4-HNE, 8-OHDG and AT8 immunoreactivity were measured using the MetaMorph software and TH⁺ cell number was estimated using stereology. Our results showed immunoreactivity for 4-HNE, 8-OHDG and AT8 within the SNc was increased in K3 mice compared to WT, and that this increase was mitigated by NIr. Results further showed that TH⁺ cell number was lower in K3 mice than in WT, and that this loss was mitigated by NIr. In summary, NIr treatment reduced the oxidative stress caused by the tau transgene in the SNc of K3 mice and saved SNc cells from degeneration. Our results, when taken together with those in other models, strengthen the notion that NIr treatment saves dopaminergic cells in the parkinsonian condition.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hyperphosphorylated tau; K369I mice; Oxidative stress; Photobiomodulation; Substantia nigra; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2013        PMID: 23998985     DOI: 10.1016/j.brainres.2013.08.047

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.610


  18 in total

1.  Photobiomodulation and the brain: a new paradigm.

Authors:  Madison Hennessy; Michael R Hamblin
Journal:  J Opt       Date:  2016-12-14       Impact factor: 2.516

Review 2.  Photobiomodulation for traumatic brain injury and stroke.

Authors:  Michael R Hamblin
Journal:  J Neurosci Res       Date:  2017-11-13       Impact factor: 4.164

Review 3.  Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Authors:  Paolo Cassano; Samuel R Petrie; Michael R Hamblin; Theodore A Henderson; Dan V Iosifescu
Journal:  Neurophotonics       Date:  2016-03-04       Impact factor: 3.593

4.  Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.

Authors:  Nabil El Massri; Ana P Lemgruber; Isobel J Rowe; Cécile Moro; Napoleon Torres; Florian Reinhart; Claude Chabrol; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

Review 5.  Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends.

Authors:  Namgue Hong
Journal:  Biomed Eng Lett       Date:  2019-06-12

6.  A safety and feasibility study of the use of 670 nm red light in premature neonates.

Authors:  A L Kent; M Broom; V Parr; R W Essex; M E Abdel-Latif; J E Dahlstrom; K Valter; J Provis; R Natoli
Journal:  J Perinatol       Date:  2015-02-19       Impact factor: 2.521

Review 7.  Current application and future directions of photobiomodulation in central nervous diseases.

Authors:  Muyue Yang; Zhen Yang; Pu Wang; Zhihui Sun
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

8.  Near-infrared light (670 nm) reduces MPTP-induced parkinsonism within a broad therapeutic time window.

Authors:  Florian Reinhart; Nabil El Massri; Daniel M Johnstone; Jonathan Stone; John Mitrofanis; Alim-Louis Benabid; Cécile Moro
Journal:  Exp Brain Res       Date:  2016-02-15       Impact factor: 2.064

9.  Photobiomodulation with near infrared light mitigates Alzheimer's disease-related pathology in cerebral cortex - evidence from two transgenic mouse models.

Authors:  Sivaraman Purushothuman; Daniel M Johnstone; Charith Nandasena; John Mitrofanis; Jonathan Stone
Journal:  Alzheimers Res Ther       Date:  2014-01-03       Impact factor: 6.982

10.  Combining neuroprotectants in a model of retinal degeneration: no additive benefit.

Authors:  Fabiana Di Marco; Mattia Di Paolo; Stefania Romeo; Linda Colecchi; Lavinia Fiorani; Sharon Spana; Jonathan Stone; Silvia Bisti
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.